Grant E. Blouse
Insider
First SEC filing: July 15, 2021 · Latest: July 15, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 9, 2022 | GYRE | P | 3,250 | $0.47 | $1,528 | 9,417 Direct | +52.70% | Acquired | 0.9% (price as of 2026-10-02) |
| Feb. 11, 2022 | GYRE | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2022 | GYRE | P | 3,250 | $0.46 | $1,495 | 6,167 Direct | +111.42% | Acquired | 3.0% (price as of 2026-10-02) |
| Aug. 9, 2021 | GYRE | P | 1,163 | $3.62 | $4,210 | 2,917 Direct | +66.31% | Acquired | -86.9% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2022 | GYRE | Stock Option (Right to Buy) | Common Stock | $0.52 | Feb. 11, 2032 | 200,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 15, 2021 | GYRE | Common Stock | 1,754 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 30,000 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 10,000 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 18,000 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 35,000 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 38,500 | Direct |
| July 15, 2021 | GYRE | Stock Option (Right to Buy) | 25,000 | Direct |